Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Indiana Medicine : the Journal of the Indiana State Medical Association|November 1, 1989
Post inferior myocardial infarction ventricular septal ruptureJ A Trippi, D E Pitts, J W Fehrenbacher, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1978
Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and manL B Turnbull, L Teng, J M Kinzie, et al.
Protein Engineering|October 1, 1996
Protein engineering loops in aspartic proteinases: site-directed mutagenesis, biochemical characterization and X-ray analysis of chymosin with a replaced loop from rhizopuspepsinP G Nugent, A Albert, P Orprayoon, et al.
Metabolism: Clinical and Experimental|April 1, 1986
Clinical experience with sorbinil--an aldose reductase inhibitorN E Pitts, F Vreeland, G L Shaw, et al.
Archives of General Psychiatry|December 1, 1995
The reliability and validity of two structured diagnostic interviews for personality disordersP A Pilkonis, C L Heape, J M Proietti, et al.
Protein Engineering|December 23, 1998
A 2.3 A resolution structure of chymosin complexed with a reduced bond inhibitor shows that the active site beta-hairpin flap is rearranged when compared with the native crystal structureM R Groves, V Dhanaraj, M Badasso, et al.
Drugs|January 1, 1986
Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathyN E Pitts, K Gundersen, D J Mehta, et al.
Clinical Science (London, England : 1979)|June 1, 1988
Atrial natriuretic peptide released by rapid ventricular pacing in dogs does not cause a natriuresisK P Walsh, T D Williams, R Canepa-Anson, et al.
Lancet (London, England)|November 16, 2002
C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective studyCarlos A Labarrere, Joshua B Lee, David R Nelson, et al.
The Journal of Biological Chemistry|May 7, 2003
Characterization of the Shewanella oneidensis MR-1 decaheme cytochrome MtrA: expression in Escherichia coli confers the ability to reduce soluble Fe(III) chelatesKaty E Pitts, Paul S Dobbin, Francisca Reyes-Ramirez, et al.
Pageof 9